Australian Entrepreneur Uses AI to Create First Custom mRNA Cancer Vaccine for Dog

Paul Conyngham, a Sydney-based tech entrepreneur, developed a bespoke mRNA cancer vaccine using AI to treat his dog Rosie after conventional treatments failed. The vaccine notably shrank Rosie's tumors, marking an innovative milestone in veterinary precision medicine. This case underscores AI's emerging role in cancer therapies and sets a precedent for future applications in human medicine.